483
Carlos Timaran, MDFDA 483 - Carlos Timaran, MD - January 15, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Mirza S. Baig, MD, Clinical Investigator in Dallas, TX, revealed significant deficiencies in the conduct of a clinical study. The firm failed to promptly report serious adverse events to the Institutional Review Board and maintained inaccurate and incomplete subject case history records. These issues indicate a lack of adherence to investigational plans and proper documentation practices.
- Office
- Dallas District Office
- Person
Open in Dashboard
ID · 45ac1f54-c66b-4439-abf8-7e142aee4ad0